Satellite symposia

The IDF Virtual Congress 2021 includes a series of high-level satellite symposia that will take place on each day of the Congress.

Renowned speakers will present their research followed by a Q&A session. The satellite symposia are scientifically oriented and reviewed by the Programme Committee for balance and rigour.

Don’t miss out on these excellent sources of additional education. They will also be available for view on-demand after the congress.

Discover the full satellite symposia programme here.

Monday, December 6
15:00-16:15
Reaching therapeutic goals in type 2 diabetes: what we have learned
Programme

Chair: Chantal Mathieu, Belgium

15:00-15:05 - Introduction and programme objectives
Chantal Mathieu, Belgium

15:05-15:20 - Insulin: from soluble to combinations
Juliana Chan, China

15:20-15:35 - How the evolution of insulins has improved our approach to preventing hypoglycaemia
Brian M Frier, United Kingdom

Programme

15:35-15:50 - Insulin delivery: Closing the loop
Steven Russell, USA

15:50-16:05 - Fixed dose combinations and other strategies to managing type 2 diabetes
Chantal Mathieu, Belgium

16:05-16:15 - Panel discussion/Q&A session

This programme is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Novo Nordisk A/S

Previous
Next
Tuesday, December 7
13:45-14:45
Recent issues in type 2 diabetes
Programme

Including Hellmut Mehnert Award Presentation 2021

Chairs: Antonio Ceriello, Rury R. Holman

13:45-13:48: Welcome
Antonio Ceriello, Italy

13:48-13:52: Introduction to the Award
Rury R. Holman, UK

13:52-13:55: Video message by Hellmut Mehnert
Oliver Schnell, Germany

Programme

13:55-14:00: Laudation and presentation of awardees
Rury R. Holman, UK; Eberhard Standl, Germany

14:00-14:22: Awardee lecture
Itamar Raz, Israel

14:22-14:44: Awardee lecture
Juliana Chan, China

14:44-14:45: Summary and close
Antonio Ceriello, Italy

Previous
Next
Tuesday, December 7
10:15-11:45
A human-machine competition in diabetes management
Programme

Chair: Linong Ji, China

10:15-10:55: An international human-machine competition for case based comprehensive management of diabetes

10:55-11:10: Application of AI technology in Endocrinology and Metabolism
Guotong Xie, China

Programme

11:10-11:25: Current state of AI applications in diabetes
Chaitanya Mamillapalli, USA

11:25-11:45: Panel discussion on the perspective of AI and diabetes management
Chair: Professor Linong Ji; Panelists: Guotong Xie, Chaitanya Mamillapalli, Patrick J O’Connor, Viswanathan Mohan

Previous
Next
Tuesday, December 7
13:45-14:45
Oral Hypoglycaemic Agents Fact Checking - Adjusting treatment options to real-world practice
Programme

Co-Chairs: SP. Chan, Malaysia; David Matthews, UK

13:45-13:50: Introduction
David Matthews, UK

13:50-14:05: Glycemic control in T2D management: Why, When and How to reach targets?
David Matthews, UK

14:05-14:20: Gluco-centric and cardio-centric treatment options: 1 approach or both?
SP Chan, Malaysia

Programme

14:20-14:35: New Real-World Evidence on Sulphonylureas use in Asia – The JADE registry
L.L Lim, Malaysia

14:35-14:45: Conclusion
SP. Chan, Malaysia

Previous
Next
Wednesday, December 8
13:45-14:45
Modern management of refractory painful diabetic neuropathy Including high-frequency spinal cord stimulation
Programme

Chair: Rodica Pop-Busui, USA

13:45-13:50: Introduction and Educational Objectives
Rodica Pop-Busui, USA

13:50-14:05: Current management of pain in diabetic peripheral neuropathy
Gordon Smith, USA

14:05-14:20: Painful diabetic peripheral neuropathy: A guidance at last
Solomon Tesfaye, UK

Programme

14:20-14:35: Update of High-Frequency Spinal Cord Stimulation for Diabetic Peripheral Neuropathy
Erika Petersen, USA

14:35-14:45: Q&A

This programme is supported by an educational grant from Nevro Corp.

Previous
Next
Tuesday, December 7
13:45-14:45
From Outdated to Updated – Evolving with Real-Time CGM
Programme

Chair: Mei Wen Foo, Singapore

13:45-13:50: Introduction
Mei Wen Foo, Singapore

13:50-14:05: Keeping up with the evolution of CGM
Pieter Gillard, Belgium, Margaretha Visser, USA

14:05-14:20: Keeping up with the standard of care
Viral Shah, USA

14:20-14:35: Keeping up with what’s next
Grazia Aleppo, USA

Previous
Next
Thursday, December 9
13:45-14:45
Chronic kidney disease and Type 2 Diabetes: benefits of the MR antagonism
Programme

Chair: Peter Rossing, Denmark

13:45-13:50: Welcome and introduction
Peter Rossing, Denmark

13:50-14:05: Addressing unmet needs in chronic kidney disease and type 2 diabetes
Per-Henrik Groop, Finland

14:05-14:20: New renal and cardiovascular results with Finerenone
Alice Cheng, Canada

Programme

14:20-14:35: Chronic kidney disease and type 2 Diabetes: Clinical perspectives with nonsteroidal MR antagonists
Jennifer Green, USA

14:35-14:45: Discussion and closure

This programme is supported by a medical education grant from Bayer AG

Previous
Next
Wednesday, December 8
13:45-14:45
Cause and effect in diabetes and COVID-19
Programme

Chair: Clifford Bailey, UK

13:50-14:05: Impact of diabetes on COVID-19
Assoc. Prof. Aimee Andag-Silva, Philippines

14:05-14:20: Impact of COVID-19 on diabetes
Jean Claude Mbanya, Cameroon

14:20-14:35: Impact of metformin on COVID-19
Clifford Bailey, United Kingdom

Previous
Next
Friday, December 10
13:45-14:45
Topical Oxygen Therapy for Diabetic Foot Ulcers: New Evidence
Programme

Chair: David Armstrong, USA

13:45-13:50: Introduction and objectives
David Armstrong, USA

13:50-14:05: Development of oxygen therapy for diabetic foot ulcers over the last century
Thomas Wild, Germany

14:05-14:20: Topical oxygen therapies now have an evidence base
Robert Frykberg, USA

Programme

14:20-14:35: Modern management of complex diabetic foot ulcers
Michael Edmonds, UK

14:35-14:45: Q&A

This programme is supported by an educational grant from Advanced Oxygen Therapy Inc.

Previous
Next
Share
Share
Share